首页> 美国卫生研究院文献>Biochemical Journal >Molecular characterization of recombinant T1 a non-allergenic periwinkle (Catharanthus roseus) protein with sequence similarity to the Bet v 1 plant allergen family.
【2h】

Molecular characterization of recombinant T1 a non-allergenic periwinkle (Catharanthus roseus) protein with sequence similarity to the Bet v 1 plant allergen family.

机译:重组T1(一种非过敏性长春花(Catharanthus roseus)蛋白)的分子特征与Bet v 1植物过敏原家族具有序列相似性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

More than 25% of the population suffer from Type I allergy, an IgE-mediated hypersensitivity disease. Allergens with homology to the major birch ( Betula verrucosa ) pollen allergen, Bet v 1, belong to the most potent elicitors of IgE-mediated allergies. T1, a cytokinin-inducible cytoplasmic periwinkle ( Catharanthus roseus ) protein, with significant sequence similarity to members of the Bet v 1 plant allergen family, was expressed in Escherichia coli. Recombinant T1 (rT1) did not react with IgE antibodies from allergic patients, and failed to induce basophil histamine release and immediate-type skin reactions in Bet v 1-allergic patients. Antibodies raised against purified rT1 could be used for in situ localization of natural T1 by immunogold electron microscopy, but did not cross-react with most of the Bet v 1-related allergens. CD analysis showed significant differences regarding secondary structure and thermal denaturation behaviour between rT1 and recombinant Bet v 1, suggesting that these structural differences are responsible for the different allergenicity of the proteins. T1 represents a non-allergenic member of the Bet v 1 family that may be used to study structural requirements of allergenicity and to engineer hypo-allergenic plants by replacing Bet v 1-related allergens for primary prevention of allergy.
机译:超过25%的人口患有I型过敏,这是IgE介导的超敏性疾病。与主要桦树(Betula verrucosa)花粉过敏原(Bet v 1)具有同源性的过敏原属于IgE介导的过敏最有效的诱发剂。 T1是一种细胞分裂素诱导的胞质长春花蛋白(Catharanthus roseus)蛋白,与Bet v 1植物过敏原家族的成员具有明显的序列相似性,在大肠杆菌中表达。重组T1(rT1)不与过敏患者的IgE抗体反应,并且在Bet v 1过敏患者中未能诱导嗜碱性粒细胞组胺释放和即刻型皮肤反应。针对纯化的rT1产生的抗体可通过免疫金电子显微镜用于天然T1的原位定位,但不会与大多数Bet v 1相关的过敏原发生交叉反应。 CD分析显示,rT1和重组Bet v 1之间在二级结构和热变性行为方面存在显着差异,表明这些结构差异是蛋白质的不同致敏性的原因。 T1代表Bet v 1家族的非变应原成员,可用于研究变应原性的结构要求并通过替代Bet v 1相关变应原来设计低变应原植物,从而初步预防过敏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号